Patents by Inventor Carl Huang

Carl Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acids encoding anti-TREM-1 antibodies
    Patent number: 11952420
    Abstract: Provided herein are antibodies, or antigen-binding portions thereof, that specifically bind and inhibit TREM-1 signaling, wherein the antibodies do not bind to one or more Fc?Rs and do not induce the myeloid cells to produce inflammatory cytokines. Also provided are uses of such antibodies, or antigen-binding portions thereof, in therapeutic applications, such as treatment of autoimmune diseases.
    Type: Grant
    Filed: September 10, 2021
    Date of Patent: April 9, 2024
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Achal Pashine, Michael L Gosselin, Aaron P. Yamniuk, Derek A. Holmes, Guodong Chen, Priyanka Apurva Madia, Richard Yu-Cheng Huang, Stephen Michael Carl
  • PROCESS FOR MAKING FLEXIBLE, POROUS, DISSOLVABLE SOLID SHEET ARTICLES WITH IMPROVED PORE STRUCTURES
    Publication number: 20240092990
    Abstract: This provides an improved process for making a flexible, porous, dissolvable solid sheet article with improved pore structures.
    Type: Application
    Filed: November 8, 2023
    Publication date: March 21, 2024
    Inventors: Hongsing TAN, Robert Wayne GLENN, JR., Carl David MAC NAMARA, Todd Ryan THOMPSON, Jason Allen STAMPER, John Philip HECHT, Xu HUANG, Ruizhi PEI, Paolo Efrain PALACIO MANCHENO, Toshiyuki OKADA
  • Antibodies against IL-7R alpha subunit and uses thereof
    Patent number: 11919962
    Abstract: Provided herein are antibodies that bind to the alpha subunit of an IL-7 receptor (IL-7R?). Also provided are uses of these antibodies in therapeutic applications, such as treatment of inflammatory diseases. Further provided are cells that produce the antibodies, polynucleotides encoding the heavy and/or light chain regions of the antibodies, and vectors comprising the polynucleotides.
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: March 5, 2024
    Assignee: Bristol Myers-Squibb Company
    Inventors: Aaron Paul Yamniuk, Scott Ronald Brodeur, Ekaterina Deyanova, Richard Yu-Cheng Huang, Yun Wang, Alfred Robert Langish, Guodong Chen, Stephen Michael Carl, Hong Shen, Achal Mukundrao Pashine, Lin Hui Su
  • Anti-TREM-1 antibodies and uses thereof
    Patent number: 11919954
    Abstract: Provided herein are antibodies, or antigen-binding portions thereof, that specifically bind and inhibit TREM-1 signaling, wherein the antibodies do not bind to one or more Fc?Rs and do not induce the myeloid cells to produce inflammatory cytokines. Also provided are uses of such antibodies, or antigen-binding portions thereof, in therapeutic applications, such as treatment of autoimmune diseases.
    Type: Grant
    Filed: September 10, 2021
    Date of Patent: March 5, 2024
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Achal Pashine, Michael L. Gosselin, Aaron P. Yamniuk, Derek A. Holmes, Guodong Chen, Priyanka Apurva Madia, Richard Yu-Cheng Huang, Stephen Michael Carl
  • Detachable personal computer
    Patent number: 6944014
    Abstract: A detachable personal computer is constructed to include a protective panel, a support arm pivoted to the protective panel and moved in and out of a receiving recess in the base of the protective panel, a keyboard coupled to the protective panel and moved in and out of a keyboard mounting opening in the protective panel, and a tablet PC detachably coupled to the protective panel and adjustably supported on the protective panel in any one of a series of tilted positions by the support arm.
    Type: Grant
    Filed: July 29, 2003
    Date of Patent: September 13, 2005
    Assignee: Tatung Co., Ltd.
    Inventors: Ching-Jou Chen, Tzu-Wei Lai, Carl Huang, Eric Wang
  • Detachable personal computer
    Publication number: 20040160738
    Abstract: A detachable personal computer is constructed to include a protective panel, a support arm pivoted to the protective panel and moved in and out of a receiving recess in the base of the protective panel, a keyboard coupled to the protective panel and moved in and out of a keyboard mounting opening in the protective panel, and a tablet PC detachably coupled to the protective panel and adjustably supported on the protective panel in any one of a series of tilted positions by the support arm.
    Type: Application
    Filed: July 29, 2003
    Publication date: August 19, 2004
    Applicant: Tatung Co., Ltd.
    Inventors: Ching-Jou Chen, Tzu-Wei Lai, Carl Huang, Eric Wang
  • Prolonged activity nicotine patch
    Patent number: 4943435
    Abstract: A transdermal patch for delivering nicotine for prolonged periods of 12-24 hours. The patch includes a rate-controlling membrane or monolith to keep the nicotine flux within useful and safe limits. The patch is typically replaced once a day, and can be used for smoking cessation therapy or in other situations where systemic nicotine delivery is indicated.
    Type: Grant
    Filed: October 28, 1988
    Date of Patent: July 24, 1990
    Assignee: Pharmetrix Corporation
    Inventors: Richard W. Baker, Frank Kochinke, Carl Huang
  • Novel transdermal nicotine patch
    Patent number: 4839174
    Abstract: A controlled release transdermal delivery system for nicotine administration. The system comprises an impermeable backing layer, a polyurethane matrix layer containing between about 5 wt % and 50 wt % nicotine, and an adhesive skin-contacting layer. The system is designed to administer nicotine for smoking cessation therapy or other uses over a period of 24 hours or more.
    Type: Grant
    Filed: October 5, 1987
    Date of Patent: June 13, 1989
    Assignee: Pharmetrix Corporation
    Inventors: Richard W. Baker, Frank Kochinke, Carl Huang